Hosted on MSN3d
FDA: No IV glutathione product approved for skin whitening
The Food and Drug Administration said Tuesday that no IV glutathione product in the Philippines was approved for skin whitening.
Hosted on MSN4d
FDA flags vlogger Rosmar Tan over ‘unauthorized’ beauty products
The Food and Drug Administration (FDA) has warned the public against buying and using beauty soaps made under the brand of ...
Manila Bulletin4d
Public warned against IV glutathione use following viral video
The Philippine Dermatological Society (PDS) has warned the public about the risks of intravenous (IV) glutathione following a ...
Inquirer on MSN3d
Public warned anew vs side effects of injectable glutathione
The Philippine Dermatological Society (PDS) again reminded the public on Monday that injectable glutathione is not approved by local authorities for skin whitening and can ...
BusinessWorld5d
Agricultural output may have contracted in 2024
PHILIPPINE FARM OUTPUT likely contracted in 2024, reflecting the adverse impact of weather-related events such as El Niño and La Niña, analysts said.
Sun Star6d
FDA warns vs consultants for FDA authorizations
THE Food and Drug Administration (FDA) on Friday, January 24, 2025, advised all health product establishments and their ...
Le Lézard10h
Weekly Roundup: 12 Health Press Releases You Need to See
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most ...
BusinessMirror2d
No studies, clinical trials support use of IV glutathione as a skin-lightening agent, says PDS president
LAST weekend, a Filipina recounted her experience in a video after a beauty procedure where she underwent an intravenous (IV) glutathione procedure. That video has already gone viral and shows the ...
Journal10h
Cua to DOH: Where is Dengue vaccine?
Why is there still no dengue vaccine in the country?” This was the question posed by Union of Local Authorities of the Philippines president and Quirino governor Dax Cua to the Department of Health, a ...
Renalys Pharma Announces Completion Of Patient Enrollment In Registrational Phase III Clinical Trial Of Sparsentan For Iga Nephropathy In Japan
TOKYO, Jan. 30, 2025 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced today that it has completed patient enrollment for its registrational Phase III ...
Le Lézard10h
Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in the European Union
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...
BusinessMirror2d
PHL seen completing field trials for bird flu vaccines in March
The long-awaited bird flu vaccines are expected to hurdle field trials by the end of March this year, according to the Department of Agriculture (DA). Agriculture Assistant Secretary Arnel de Mesa ...